Efficiency of adenovirus-mediated gene transfer into hepatocytes by liver asanguineous perfusion method

Research in Experimental Medicine

Volumn 199, Issue 5, 1999, Pages 263-274

  Futagawa, Yasuro ^a   Okamoto, Tomoyoshi ^a   Ohashi, Toya ^a   Eto, Yoshikatsu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenovirus; Gene transfer; Liver; Perfusion

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLAMP; ENZYME ACTIVITY; GENE THERAPY; LIVER CELL; LIVER DISEASE; LIVER PERFUSION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RAT; SAFETY;

EID: 0034007743     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004330050124     Document Type: Article

References (23)

1. 1. Adam R, Poggi L, Capron M, Morin J, Gigou M, Miramand JC, Szekely AM, Houssin D (1987) Asanguineous isolated hyperthermic in vivo perfusion of the liver in the rat. Eur Surg Res 19:366-374
2. 2. Arbuthnot PB, Bralet MP, Jossic CL, Dedieu JF, Perricaudet M, Brechot C, Ferry N (1996) In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 7:1503-1514
3. 3. Barr DJ, Tubb D, Lieber A, Perkins AJ, Kay MA (1995) Strain related variations in adenovirally-mediated transgene expression in mouse heptocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 2:151-155
4. 4. Cardoso JE, Branchereau S, Jeyaraj PR, Houssin D, Danos O, Heard JM (1993) In situ retrovirus-mediated gene transfer into dog liver. Hum Gene Ther 4:411-418
5. 5. Drazen KE, Csete ME, Shen XD, Bullington D, Cottle G, Busuttil RW, Shaked A (1995) Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J Surg Res 59:299-304
6. 6. Fang B, Eisensmith RC, Li XHC, Finegold MJ, Shedlovsky A, Dove W, Woo SLC (1994) Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther 1: 247-254
7. 7. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq JP, Crystal RG (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature 1:372-378
8. 8. Kanegae Y, Makimura M, Saito I (1994) A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157-166
9. 9. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I (1995) Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23:3816-3821
10. 10. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLC (1994) In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353-2357
11. 11. Kitten O, Cosset FL, Ferry N (1997) Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. Hum Gene Ther 8:1491-1494
12. 12. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SLC (1993) Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 4: 403-409
13. 13. Monahan P, Samulski R, Tazelaar J, Xiao X, Nichols T, Bellinger D, Read M, Walsh C (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40-49
14. 14. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200
15. 15. Okamoto T, Futagawa Y, Inagaki Y, Aoki T, Ohashi T (1997) The experimental study of the delivery method on the gene transfer into hepatocytes with recombinant adenovirus. Nippon Geka Gakkai Zasshi 98:656
16. 16. Peeters MJTFDV, Lieber A, Perkins J, Kay MA (1996) Method for multiple portal infusions in mice: Quantitation of adenovirus-mediated hepatic gene transfer. Biotechniques 20:278-285
17. 17. Roos WD, Fallaux F, Marinelli A, Lazaris-Karatzas A, Geusau BAV, Eb MVD, Cramer S, Terpstra O, Hoeben R (1997) Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4:55-62
18. 18. Rozga J, Moscioni AD, Neuzil D, Demetriou AA (1992) A model for directed foreign gene delivery to rat liver cells in vivo. J Surg Res 52:209-213
19. 19. Sanes JR, Rubenstein JLR, Nicolas JF (1986) Use of a recombinant retrovirus? To study post-implantation cell lineage in mouse embryos. EMBO J 5:3133-3142
20. 20. Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, Mcclelland A, Kaleko M (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402
21. 21. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270-276
22. 22. Yang Y, Ertl HCJ, Wilson JM (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442
23. 23. Yang Y, Li Q, Ertl HCJ, Wilson JM (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015